Curie.Bio is a new model for venture capital in biotech. We are focused on a singular mission – helping founders launch therapeutics companies that go on to ...
안정적인 제품 공급을 위한 본사 차원의 끊임없는 노력에도 불구하고, 계속되는 국제적인 정치 상황 및 경제 불안으로 인해 원자재 가격, 생산비 및 운송비 변동이 지속됨 ...
First-in-class medicine in similar concept with currently popular immunotherapy in respect that pipe-line of CURE BIO uses the disease treating in-vivo ...
Curie.Bio is run by a unique blend of world class biotech founders, operators, and early-stage investors. Our collective team has brought over ~150 drugs into ...
This device uses clinical-grade LEDs to delivery powerful irradiance for highly effective therapy.
Explore Curebio Therapeutics with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Endocrinology and Metabolic Disease, ...
We are the front-runner in the field of ARS(Aminoacyl-tRNA Synthetase)-based therapeutics, developing first-in-class anti-tumorigenic peptide drugs.
직접 검색 ; Curebio Buffer, CBM-S0138-500ml, Saline Solution, 0.9％, Sterile ; CureBio Buffer, CBM-T2508-500ml, Tyrodes Buffer (cell culture grade) ...
ARS 원천기술 플랫폼을 기반으로 신약을 개발하는 아시아 최초 기업 · KRS. 면역조절 항섬유화제 (폐동맥 고혈압) · GRS. 항암 신기전 치료제 (신장암/간암/폐암/난소암).
This is a default index page for a new domain.